Lv11
10 积分 2022-01-23 加入
Preclinical efficacy of potent and selective menin-KMT2A inhibitor JNJ-75276617 in KMT2A- and NPM1-altered leukemias
51分钟前
已关闭
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study
1小时前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
29天前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
1个月前
已完结
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome
1个月前
已关闭
Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia
1个月前
已完结
Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors
1个月前
已完结
How I Treat: Differentiation Therapy in Acute Myeloid Leukemia
1个月前
已完结
How I Treat: Differentiation Therapy in Acute Myeloid Leukemia
1个月前
已关闭
皖公网安备34019202002308
